Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06793891 · ClinicalTrials.gov registry record · NA
Effects of Ashwagandha Extract on Stress Levels
A NA study of Stress, sponsored by Nutraceuticals Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06793891: Recruiting NA study of Stress, sponsored by Nutraceuticals Research Institute.
NCT06793891 is a NA study of Stress that is actively recruiting participants, run by Nutraceuticals Research Institute. The registered enrollment target is 60 participants, below the 786-participant average among 152 other Stress trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06793891, a NA study of Stress, is actively recruiting participants, sponsored by Nutraceuticals Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the efficacy of two proprietary ashwagandha extracts on stress levels, with secondary outcomes of cognition, energy, and sleep, as compared to a placebo.
Primary Outcome
salivary cortisol levels will be taken immediately after waking and 30 minutes later to produce a composite score
Conditions Studied
Interventions
- OTHER placebo
- DIETARY_SUPPLEMENT ashwagandha root
- DIETARY_SUPPLEMENT ashwagandha root and leaf
Study Locations (1)
Alabama
- Nutraceuticals Research Institute - Huntsville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-10-21 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
What NCT06793891 shows while recruiting
NCT06793891 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 786-participant average among 152 other Stress trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Stress appearing as the primary indexed condition, and to 3 interventions - of which placebo is the first listed.
NCT06793891 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06793891 about?
NCT06793891 is a clinical study titled "Effects of Ashwagandha Extract on Stress Levels". The purpose of this study is to evaluate the efficacy of two proprietary ashwagandha extracts on stress levels, with secondary outcomes of cognition, energy, and sleep, as compared to a placebo.
What is the current status of trial NCT06793891?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-10-21. Estimated completion is 2025-04-30.
What conditions does trial NCT06793891 study?
This clinical trial studies the following conditions: Stress.
What interventions are being tested in trial NCT06793891?
The interventions under investigation include: placebo (OTHER), ashwagandha root (DIETARY_SUPPLEMENT), ashwagandha root and leaf (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06793891?
This trial is sponsored by Nutraceuticals Research Institute, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06793891 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06793891's enrollment target sits among peer trials
60 91st of 152 higher than 57 of 152 other Stress trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness-Based Intervention With a Supplement for Stress-Related Problems in College Students Across Multiple Sites (4SITE)
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
ACT for HIV-Positive Men
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI